Delcath Issues Letter to Shareholders
September 22, 2017 08:30 ET
|
Delcath Systems, Inc.
NEW YORK, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Data on Delcath’s CHEMOSAT System Presented at CIRSE Annual Meeting
September 19, 2017 08:30 ET
|
Delcath Systems, Inc.
NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Announces Accelerated Listing on OTCQB
September 14, 2017 16:15 ET
|
Delcath Systems, Inc.
NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Announces Relisting on OTCQB
September 13, 2017 06:30 ET
|
Delcath Systems, Inc.
NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
Delcath Issues Letter to Stockholders
September 01, 2017 10:10 ET
|
Delcath Systems, Inc.
NEW YORK, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq:DCTH) (the "Company"), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers,...
Delcath Announces Medical University of Hannover in Germany Celebrates 100th CHEMOSAT Treatment
August 29, 2017 06:30 ET
|
Delcath Systems, Inc.
NEW YORK, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, congratulates...
Delcath Announces Agreement for Extinguishment of Convertible Notes with Majority Holder
August 28, 2017 06:30 ET
|
Delcath Systems, Inc.
Agreement Contingent upon Shareholder Vote in Favor of the Proposed Reverse Stock Split Voting Deadline Extended to September 7, 2017 NEW YORK, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Delcath Systems,...
Delcath Systems, Inc. Announces Extension of Expiration Date of its Consent Solicitation and Ability to Change Consent Once Voted
August 22, 2017 08:30 ET
|
Delcath Systems, Inc.
NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH) (the “Company”) announced today that the deadline for its current Consent Solicitation (the “Consent Solicitation”),...
Delcath Systems, Inc. Announces Adjournment of Annual Meeting Meeting Scheduled to Reconvene on June 16
June 05, 2017 17:15 ET
|
Delcath Systems, Inc.
NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH) (the “Company”) announced today that its 2017 Annual Meeting of Stockholders (the “Annual Meeting”), scheduled for...
Delcath Announces First Quarter 2017 Financial Results
May 09, 2017 08:00 ET
|
Delcath Systems, Inc.
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces...